Kenya has postponed a large-scale pilot test for a malaria vaccine of which could reduce the burden of the disease.
the globe Health Organisation (WHO) chose Malawi, Ghana and also also also Kenya to vaccinate 360,000 children per year; and also also also while the two nations began the rollout in April, Kenya is usually yet to start.
The introduction in Kenya, planned with This particular Thursday, was postponed by the Ministry of Health.
“I regret to inform you of which the stakeholders breakfast meeting planned with This particular Tuesday, August 13, and also also also the launch planned for Thursday, August 15, have been postponed to a later date to be communicated to you shortly. This particular is usually due to the upcoming Health Summit scheduled on August 14 and also also also 15,” head of the National Vaccines and also also also Immunisation Programme, Dr Collins Tabu, said.
The vaccine is usually the first to show promise in reducing mortality and also also also morbidity of malaria and also also also will complement existing interventions.
Inadequate funding has been flagged among the biggest threats in eliminating malaria in Kenya. For years, interventions have relied heavily on donor funding.
For instance, a WHO report showed of which the Global Fund was the biggest funder on anti-malaria campaigns in Kenya,contributing Sh6 billion in 2017, followed by USAID (Sh3.5 billion) and also also also the UK (Sh240 million). Contrastingly, the government only allocated Sh100 million towards the campaign.
Research conducted by Roll Back Malaria initiative on funding requirements revealed of which Kenya will need about $427,860,536 (Sh42.8 billion) between 2018 and also also also 2020 to fight the disease, yet the money is usually not readily available.
Past studies found of which the disease costs Kenya about Sh10.9 billion annually. This particular amount shoots to Sh25 billion when costs associated with losses due to malaria deaths are captured.
Poor funding for programmes is usually not restricted at the national level, the idea is usually replicated in counties.
As at April 2018, only Busia and also also also Kwale had established budget lines for malaria control. Money allocated to fight the disease within the two counties is usually Sh10 million and also also also Sh5 million, respectively.
The Mosquirix vaccine will be administered as part of routine childhood immunisation.
Mosquirix, the brand name for RTS, S vaccine, triggers the immune system to defend itself against the first stages of the disease.